Ridgetech (RDGT)
China-focused B2B pharmaceutical wholesale and online distributor.
Something off on this page? Send us feedback.
Resells pharmaceuticals, healthcare products and everyday goods through Jiuxin Medicine's local wholesale operation and Allright's nationwide online platforms. The low-margin offline base supplies most sales, while the Cayman parent depends on PRC operating entities, regulated licenses and third-party digital channels.
Distributes third-party pharmaceuticals and healthcare products in China through Jiuxin Medicine's offline wholesale operation and Allright's online platform. Jiuxin supplies prescription and over-the-counter medicines, traditional Chinese medicine, supplements, medical devices and personal-care goods to vendors, trading companies and hospitals in local markets.
Allright sells pharmaceuticals, medical devices, health foods and daily necessities to pharmacies, small chains, clinics and other vendors across China through its own and third-party platforms. Its proprietary platform is designed to add medication guidance, sales-management and customer-health functions, though sales through it remained limited in the annual reporting period.
Combines a low-margin wholesale base with a digital B2B channel that extends distribution nationwide. All material operations and product sales are in China, where wholesale and online sales require licenses and permits and the Cayman parent relies on PRC entities for funds subject to distribution and foreign-exchange constraints.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $17.9M · Total debt $22.7K · Total assets $69.0M · Shareholders' equity $40.8M
- Revenue
- $69.4M
- Operating income
- −$1.8M
- Net income
- −$1.2M
No dividends on record.
| Insiders1 holder · as of Jul 20, 2026 | 247.52% | 2.23M shares | |
| Strategic holders1 holder · as of Jul 2, 2026 | 18.05% | 162.3K shares | |
| Adds to | 265.57% |
898.9K company shares as of Aug 21, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
These groups come from separate filings that can overlap, so they add to 265.57%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Lingtao Kong1Insiderdirector | 247.52% | 2.23M | Form 4filed Jul 20, 2026 ↗ |
HRT Financial LPStrategic10 percent owner | 18.05% | 100,499 · 61,753 | Form 4filed Jul 2, 2026 ↗ |
- Reported at 3.20% on Jul 20, 2026, under the 5% line, so no further filing is required.
Form 4 — an insider's transaction report
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 16, 2026 | Lingtao Kong | director | +100,000 | |
| Jun 30, 2026 | HRT Financial LP | 10 percent owner | +30,939 | $1.52 |
| Jul 1, 2026 | HRT Financial LP | 10 percent owner | +10,197 | $1.50 |
| Jun 16, 2026 | HRT Financial LP | 10 percent owner | −57,998 | $1.60 |
| Jun 15, 2026 | HRT Financial LP | 10 percent owner | −8,091 | $1.60 |
Not reported.